Krupa Naran (K Naran)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Chronic Obstructive Pulmonary Disease

Top Venues

Immunotherapy advances

Journal of cancer research and clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Neelakshi Mungra, Fleury Augustin Nsole Biteghe, Zaria Malindi, Allan M Huysamen, Maryam Karaan, Natasha S Hardcastle, Rubina Bunjun, Shivan Chetty, Krupa Naran, Dirk Lang, Wolfgang F Richter, Roger Hunter, Stefan Barth
CSPG4 as a target for the specific killing of triple-negative breast cancer cells by a recombinant SNAP-tag-based antibody-auristatin F drug conjugate. Journal of cancer research and clinical oncology (2023)
Stefan Barth, Krupa Naran
TIM-3: a tumor-associated antigen beyond checkpoint inhibition? Immunotherapy advances 2 (1) (2022)
A K Daramola, O A Akinrinmade, E A Fajemisin, Krupa Naran, N Mthembu, S Hadebe, F Brombacher, A M Huysamen, O E Fadeyi, R Hunter, S Barth
A recombinant Der p 1-specific allergen-toxin demonstrates superior killing of allergen-reactive IgG + hybridomas in comparison to its recombinant allergen-drug conjugate. Immunotherapy advances 3 (1) (2022)
A K Daramola, O A Akinrinmade, E A Fajemisin, Krupa Naran, N Mthembu, S Hadebe, F Brombacher, A M Huysamen, O E Fadeyi, R Hunter, S Barth
A recombinant Der p 1-specific allergen-toxin demonstrates superior killing of allergen-reactive IgG + hybridomas in comparison to its recombinant allergen-drug conjugate. Immunotherapy advances 3 (1) (2022)